KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $834.3 million.

  • Medpace Holdings' Current Deferred Revenue rose 2435.23% to $834.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $834.3 million, marking a year-over-year increase of 2435.23%. This contributed to the annual value of $710.6 million for FY2024, which is 2692.19% up from last year.
  • Per Medpace Holdings' latest filing, its Current Deferred Revenue stood at $834.3 million for Q3 2025, which was up 2435.23% from $808.8 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Current Deferred Revenue ranged from a high of $834.3 million in Q3 2025 and a low of $277.8 million during Q1 2021
  • Over the past 5 years, Medpace Holdings' median Current Deferred Revenue value was $490.6 million (recorded in 2023), while the average stood at $520.6 million.
  • In the last 5 years, Medpace Holdings' Current Deferred Revenue skyrocketed by 4996.55% in 2021 and then surged by 1654.28% in 2025.
  • Over the past 5 years, Medpace Holdings' Current Deferred Revenue (Quarter) stood at $344.6 million in 2021, then skyrocketed by 34.26% to $462.7 million in 2022, then increased by 20.99% to $559.9 million in 2023, then grew by 26.92% to $710.6 million in 2024, then rose by 17.41% to $834.3 million in 2025.
  • Its Current Deferred Revenue stands at $834.3 million for Q3 2025, versus $808.8 million for Q2 2025 and $718.7 million for Q1 2025.